Variant report

Variant	esv3407995
Chromosome Location	chr5:1885777-1888525
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:21)
CpG islands
(count:550)
Chromatin interactive
region (count:7)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:21 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:1887246-1887494	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTBP2	chr5:1885936-1887086	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr5:1886760-1886910	HMEC	breast:	n/a	n/a
4	CTCF	chr5:1887420-1887570	NHEK	skin:	n/a	chr5:1887502-1887511
5	CTCF	chr5:1887460-1887610	HMEC	breast:	n/a	chr5:1887502-1887511
6	CTCF	chr5:1887451-1887517	NHEK	skin:	n/a	chr5:1887502-1887511
7	E2F4	chr5:1887078-1887772	MCF10A-Er-Src	breast:	n/a	chr5:1887412-1887422 chr5:1887148-1887160 chr5:1887318-1887328
8	EGR1	chr5:1888154-1888390	K562	blood:	n/a	chr5:1888285-1888298 chr5:1888275-1888285 chr5:1888217-1888226 chr5:1888285-1888295 chr5:1888285-1888298 chr5:1888271-1888284 chr5:1888285-1888298 chr5:1888285-1888298 chr5:1888286-1888295
9	MYC	chr5:1886403-1886618	MCF10A-Er-Src	breast:	n/a	n/a
10	MYC	chr5:1886970-1887632	MCF10A-Er-Src	breast:	n/a	chr5:1887356-1887365
11	MYC	chr5:1887398-1887598	MCF10A-Er-Src	breast:	n/a	n/a
12	NFE2	chr5:1887674-1887714	GM12878	blood:	n/a	n/a
13	NR2F2	chr5:1888056-1888499	MCF-7	breast:	n/a	n/a
14	POLR2A	chr5:1881481-1891348	MCF10A-Er-Src	breast:	n/a	n/a
15	POLR2A	chr5:1882409-1891588	MCF10A-Er-Src	breast:	n/a	n/a
16	RAD21	chr5:1887492-1887688	H1-hESC	embryonic stem cell:	n/a	chr5:1887493-1887506
17	RAD21	chr5:1887274-1887882	H1-hESC	embryonic stem cell:	n/a	chr5:1887493-1887506
18	SIN3A	chr5:1886205-1886256	H1-hESC	embryonic stem cell:	n/a	n/a
19	SIN3A	chr5:1887447-1887554	H1-hESC	embryonic stem cell:	n/a	n/a
20	STAT3	chr5:1886773-1886795	MCF10A-Er-Src	breast:	n/a	n/a
21	SUZ12	chr5:1885091-1887033	H1-hESC	embryonic stem cell:	n/a	n/a

(count:550 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:1888033-1888083	U87	brain:	n/a
2	chr5:1888033-1888083	U87	brain:	n/a
3	chr5:1886309-1886359	CMK	blood:	n/a
4	chr5:1886309-1886359	GM12878	blood:	n/a
5	chr5:1887583-1887633	HepG2	liver:	n/a
6	chr5:1885950-1886000	HAEpiC	amniotic membrane:	n/a
7	chr5:1886994-1887044	PANC-1	pancreas:	n/a
8	chr5:1886994-1887044	HCF	heart:	n/a
9	chr5:1886994-1887044	Caco-2	colon:	n/a
10	chr5:1888033-1888083	NT2-D1	testis:	n/a
11	chr5:1887300-1887350	HAEpiC	amniotic membrane:	n/a
12	chr5:1887300-1887350	MCF10A-Er-Src	breast:	n/a
13	chr5:1887583-1887633	HCM	heart:	n/a
14	chr5:1887583-1887633	HCF	heart:	n/a
15	chr5:1887583-1887633	GM12891	blood:	n/a
16	chr5:1885950-1886000	HCT-116	colon:	n/a
17	chr5:1885778-1885828	SKMC	muscle:	n/a
18	chr5:1886994-1887044	ovcar-3	ovarian:	n/a
19	chr5:1886956-1887006	HCPEpiC	choroid plexus:	n/a
20	chr5:1887583-1887633	HEEpiC	esophagus:	n/a
21	chr5:1886828-1886878	RPTEC	kidney:	n/a
22	chr5:1887583-1887633	LNCaP	prostate:	n/a
23	chr5:1886309-1886359	NT2-D1	testis:	n/a
24	chr5:1885950-1886000	Caco-2	colon:	n/a
25	chr5:1886956-1887006	HEK293	kidney:	embryo
26	chr5:1885778-1885828	SK-N-MC	brain:	n/a
27	chr5:1886994-1887044	HEK293	kidney:	embryo
28	chr5:1887300-1887350	HIPEpiC	eye:	n/a
29	chr5:1886956-1887006	HNPCEpiC	eye:	n/a
30	chr5:1886309-1886359	GM12892	blood:	n/a
31	chr5:1885778-1885828	HUVEC	blood vessel:	n/a
32	chr5:1885778-1885828	Hela-S3	cervix:	n/a
33	chr5:1886994-1887044	ECC-1	luminal epithelium:	n/a
34	chr5:1886828-1886878	LNCaP	prostate:	n/a
35	chr5:1886309-1886359	SK-N-SH_RA	brain:	n/a
36	chr5:1886309-1886359	SKMC	muscle:	n/a
37	chr5:1886994-1887044	MCF-7	breast:	n/a
38	chr5:1887300-1887350	NB4	blood:	n/a
39	chr5:1886956-1887006	ProgFib	skin:	n/a
40	chr5:1887300-1887350	HRCEpiC	kidney:	n/a
41	chr5:1886828-1886878	AG09319	gingival:	n/a
42	chr5:1886828-1886878	SAEC	small airway:	n/a
43	chr5:1886994-1887044	NB4	blood:	n/a
44	chr5:1885950-1886000	NH-A	brain:	n/a
45	chr5:1887300-1887350	Hela-S3	cervix:	n/a
46	chr5:1886994-1887044	PFSK-1	brain:	n/a
47	chr5:1885950-1886000	HEK293	kidney:	embryo
48	chr5:1887300-1887350	SAEC	small airway:	n/a
49	chr5:1885950-1886000	GM06990	blood:	n/a
50	chr5:1888033-1888083	NHDF-neo	bronchial:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:1796457..1805482-chr5:1878036..1885786,21	MCF-7	breast:
2	chr5:1799569..1802884-chr5:1886598..1889173,4	MCF-7	breast:
3	chr5:1669626..1671226-chr5:1885591..1887218,2	MCF-7	breast:
4	chr5:1887482..1890226-chr5:1890300..1892183,2	MCF-7	breast:
5	chr5:1887761..1891597-chr5:1896215..1899107,3	K562	blood:
6	chr5:1887761..1890459-chr5:1897295..1899107,2	K562	blood:
7	chr5:1793765..1806799-chr5:1879445..1889322,45	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-NDUFS6-4	chr5:1888327-1888396	XLOC_004249
2	lnc-NDUFS6-4	chr5:1887445-1887483	NR_109912
3	lnc-NDUFS6-4	chr5:1887446-1887483	XLOC_004249
4	lnc-NDUFS6-4	chr5:1888327-1888396	NR_109912

No data

Variant related genes	Relation type
ENSG00000249326	TF binding region
IRX4	TF binding region
ENSG00000249326	CpG island
IRX4	CpG island
ENSG00000145494	chromatin interactions
ENSG00000171421	chromatin interactions

Extended variants
information (count: 127 )
Associated
traits (count: 113 )

Variant overlapped rSNPs/rCNVs (count:127 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs527811813	chr5:1885906-1885907	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs531377384	chr5:1885911-1885912	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs112118629	chr5:1885931-1885932	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs72706719	chr5:1885964-1885965	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs538260264	chr5:1886032-1886033	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs571169590	chr5:1886077-1886078	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs538589222	chr5:1886098-1886099	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs34451440	chr5:1886107-1886108	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs569143938	chr5:1886129-1886130	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs539740200	chr5:1886151-1886152	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs372728721	chr5:1886155-1886156	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs12517770	chr5:1886176-1886177	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs558011027	chr5:1886216-1886217	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs149161339	chr5:1886248-1886249	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs376646078	chr5:1886250-1886251	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs1493458	chr5:1886341-1886342	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs541123649	chr5:1886342-1886343	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs555458365	chr5:1886375-1886376	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs115727776	chr5:1886385-1886386	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs369357892	chr5:1886404-1886405	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs562332698	chr5:1886441-1886442	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs533494081	chr5:1886450-1886451	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs545277184	chr5:1886451-1886452	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs260400	chr5:1886471-1886472	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs527896514	chr5:1886553-1886554	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs113418587	chr5:1886575-1886576	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs138976816	chr5:1886621-1886622	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs549283977	chr5:1886643-1886644	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs559021400	chr5:1886664-1886665	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs564978886	chr5:1886689-1886690	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs6898268	chr5:1886779-1886780	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs531673828	chr5:1886790-1886791	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs113454814	chr5:1886802-1886803	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs369792579	chr5:1886816-1886817	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs550195034	chr5:1886823-1886824	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs35499180	chr5:1886843-1886844	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs36120038	chr5:1886845-1886846	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs34863731	chr5:1886859-1886860	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs189257758	chr5:1886868-1886869	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs143177191	chr5:1886876-1886877	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs112705310	chr5:1886877-1886878	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs566742339	chr5:1886885-1886886	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs533977453	chr5:1886915-1886916	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs543991423	chr5:1886916-1886917	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs147512904	chr5:1886972-1886973	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs376446807	chr5:1886974-1886975	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs13153246	chr5:1886976-1886977	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs537542905	chr5:1886981-1886982	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs549874604	chr5:1887004-1887005	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs181534534	chr5:1887019-1887020	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:113)

Disease	PMID	Source
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16608533	CNVD
Cervical cancer	16585170	CNVD
Glioblastoma multiforme	22286061	CNVD
Lung cancer	17925434	CNVD
Ovarian cancer	20844748	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Non-small cell lung cancer	21829676	CNVD
Intracranial ependymoma	16609018	CNVD
Breast cancer	19181860	CNVD
prenatal diagnosis	20453657	CNVD
Developmental delay	19490664	CNVD
Human papillomavirus	17975027	CNVD
Acute monocytic leukemia	16498392	CNVD
Gastric cancer	16891809	CNVD
Intracranial aneurysm	16715129	CNVD
Emphysema	19352772	CNVD
Chordoma	18071362	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Lung cancer	21911935	CNVD
Cri-du chat syndrome	21549014	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Sudden cardiac death	19188705	CNVD
renal disease	17924346	CNVD
abnormal development	18461090	CNVD
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21509527	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Oral cancer	22144094	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Urothelial carcinoma	21177765	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Multiple myeloma	17550852	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Developmental delay	21147756	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Melanoma	22183965	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
lymphocytic leukemia	21291569	CNVD
Autism	22495311	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Schizophrenia	23813976	CNVD
Ependymoma	20639864	CNVD

Chromatin state (count:138 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:1880800-1887800	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
2	chr5:1881400-1886800	Bivalent Enhancer	Fetal Stomach	stomach
3	chr5:1882400-1887600	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr5:1882400-1887600	Active TSS	NHEK	skin
5	chr5:1882400-1887800	Active TSS	Breast Myoepithelial Primary Cells	Breast
6	chr5:1883600-1886800	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
7	chr5:1884200-1898200	Weak transcription	Gastric	stomach
8	chr5:1884400-1886000	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
9	chr5:1884400-1886400	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
10	chr5:1884400-1887000	Weak transcription	Right Atrium	heart
11	chr5:1884800-1886400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
12	chr5:1885000-1886600	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
13	chr5:1885000-1887800	Active TSS	Esophagus	oesophagus
14	chr5:1885200-1885800	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
15	chr5:1885200-1886600	Active TSS	Fetal Heart	heart
16	chr5:1885400-1885800	Bivalent/Poised TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr5:1885400-1886200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
18	chr5:1885400-1886200	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
19	chr5:1885400-1887400	Active TSS	HMEC	breast
20	chr5:1885400-1887600	Active TSS	Right Ventricle	heart
21	chr5:1885400-1887800	Bivalent/Poised TSS	H9 Derived Neuron Cultured Cells	ES cell derived
22	chr5:1885600-1885800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
23	chr5:1885600-1886000	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
24	chr5:1885600-1886200	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr5:1885600-1887000	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr5:1885600-1887800	Active TSS	Left Ventricle	heart
27	chr5:1885800-1886000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
28	chr5:1885800-1886200	Flanking Bivalent TSS/Enh	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
29	chr5:1885800-1886200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
30	chr5:1885800-1886600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
31	chr5:1885800-1886800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
32	chr5:1886000-1886200	Flanking Bivalent TSS/Enh	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
33	chr5:1886000-1886200	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
34	chr5:1886000-1886200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr5:1886000-1886200	Enhancers	Liver	Liver
36	chr5:1886000-1886400	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
37	chr5:1886000-1886600	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr5:1886000-1887000	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
39	chr5:1886000-1887600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr5:1886000-1888200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
41	chr5:1886200-1886400	Bivalent/Poised TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chr5:1886200-1886400	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr5:1886200-1886400	Bivalent Enhancer	Brain Anterior Caudate	brain
44	chr5:1886200-1886400	Bivalent Enhancer	Stomach Smooth Muscle	stomach
45	chr5:1886200-1886600	Bivalent/Poised TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
46	chr5:1886200-1886600	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
47	chr5:1886200-1887600	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
48	chr5:1886200-1887800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
49	chr5:1886200-1888000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
50	chr5:1886200-1888000	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links